News Focus
News Focus
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

Re: rajaram46 post# 10717

Friday, 07/26/2013 11:32:32 AM

Friday, July 26, 2013 11:32:32 AM

Post# of 20689
It means Teva's 2015 process patent is unenforceable and hence MNTA/NVS (and MYL) can launch generic Copaxone in May 2014, pending FDA approval.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”